Literature DB >> 25655495

Clinical significance of intra-alveolar fibrin deposition in transbronchial lung biopsy in patients with organizing pneumonia.

Nobuhiko Nagata1, Kentaro Wakamatsu, Hiroyuki Kumazoe, Hiroyuki Miyazaki, Takanori Akagi, Masayuki Kawasaki, Kentaro Watanabe.   

Abstract

OBJECTIVE: This study examined the clinical significance of intra-alveolar fibrin deposition (IAFD) in transbronchial lung biopsy specimens obtained from patients with organizing pneumonia.
METHODS: Pathological reports of transbronchial lung biopsies performed between 2004 and 2012 were reviewed to identify cases of intra-alveolar organization with or without fibrin deposition. Clinical charts, computed tomography images, and transbronchial lung biopsy specimens from these cases were examined retrospectively. Diagnosis of organizing pneumonia was reevaluated based upon the consensus of a respiratory physician, a radiologist, and a pathologist.
RESULTS: Transbronchial lung biopsy results of the reviewed patients with organizing pneumonia found seven patients who had IAFD, and 34 who did not. Seven patients' conditions were associated with collagen vascular disease (CVD), and 34 were cryptogenic. IAFD was significantly associated with high C-reactive protein (CRP) values (>5 mg/dl) (p = 0.0012) and underlying CVD (p = 0.0099). Multivariate analysis revealed that IAFD was independently associated with high CRP values (p = 0.0184). Three of 31 patients and six of 27 patients experienced a relapse of organizing pneumonia within 6 months and 1 year, respectively. IAFD (p = 0.0044) and high CRP values (p = 0.0207) were significantly related to relapse within 6 months, while only CRP was significantly related to relapse within 1 year (p = 0.0007).
CONCLUSION: In patients with organizing pneumonia, IAFD was significantly associated with high CRP values. High CRP values and/or IAFD predicted relapse of organizing pneumonia within 6 months to 1 year.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25655495     DOI: 10.1007/s00408-015-9689-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  7 in total

1.  Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P).

Authors:  R Lazor; A Vandevenne; A Pelletier; P Leclerc; I Court-Fortune; J F Cordier
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis.

Authors:  Fotios Drakopanagiotakis; Koralia Paschalaki; Muhanned Abu-Hijleh; Bassam Aswad; Napoleon Karagianidis; Emmanouil Kastanakis; Sidney S Braman; Vlasis Polychronopoulos
Journal:  Chest       Date:  2010-08-19       Impact factor: 9.410

3.  Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia.

Authors:  Jung-Wan Yoo; Jin Woo Song; Se Jin Jang; Chang Keun Lee; Mi-Young Kim; Hyun-Kyung Lee; Yangjin Jegal; Dong Soon Kim
Journal:  Rheumatology (Oxford)       Date:  2010-12-17       Impact factor: 7.580

Review 4.  Cryptogenic organising pneumonia.

Authors:  J-F Cordier
Journal:  Eur Respir J       Date:  2006-08       Impact factor: 16.671

5.  Clinical features in secondary and cryptogenic organising pneumonia.

Authors:  O A Sveinsson; H J Isaksson; A Sigvaldason; F Yngvason; T Aspelund; G Gudmundsson
Journal:  Int J Tuberc Lung Dis       Date:  2007-06       Impact factor: 2.373

6.  Clinicopathological study on two types of cryptogenic organizing pneumonitis.

Authors:  T Yoshinouchi; Y Ohtsuki; K Kubo; Y Shikata
Journal:  Respir Med       Date:  1995-04       Impact factor: 3.415

7.  Factors related to the relapse of bronchiolitis obliterans organizing pneumonia.

Authors:  K Watanabe; S Senju; F Q Wen; T Shirakusa; F Maeda; M Yoshida
Journal:  Chest       Date:  1998-12       Impact factor: 9.410

  7 in total
  2 in total

1.  Impaired fibrinolysis in critically ill COVID-19 patients.

Authors:  Mirjam Bachler; Johannes Bösch; Daniel P Stürzel; Tobias Hell; Andreas Giebl; Mathias Ströhle; Sebastian J Klein; Volker Schäfer; Georg F Lehner; Michael Joannidis; Claudius Thomé; Dietmar Fries
Journal:  Br J Anaesth       Date:  2020-12-09       Impact factor: 9.166

2.  Clinical features of acute fibrinous and organizing pneumonia: An early histologic pattern of various acute inflammatory lung diseases.

Authors:  Yasutaka Onishi; Tetsuji Kawamura; Takanori Higashino; Rokuro Mimura; Hiroaki Tsukamoto; Shin Sasaki
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.